Literature DB >> 10540002

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

J M Cedarbaum1, N Stambler, E Malta, C Fuller, D Hilt, B Thurmond, A Nakanishi.   

Abstract

The ALS Functional Rating Scale (ALSFRS) is a validated rating instrument for monitoring the progression of disability in patients with amyotrophic lateral sclerosis (ALS). One weakness of the ALSFRS as originally designed was that it granted disproportionate weighting to limb and bulbar, as compared to respiratory, dysfunction. We have now validated a revised version of the ALSFRS, which incorporates additional assessments of dyspnea, orthopnea, and the need for ventilatory support. The Revised ALSFRS (ALSFRS-R) retains the properties of the original scale and shows strong internal consistency and construct validity. ALSFRS-R scores correlate significantly with quality of life as measured by the Sickness Impact Profile, indicating that the quality of function is a strong determinant of quality of life in ALS.

Entities:  

Mesh:

Year:  1999        PMID: 10540002     DOI: 10.1016/s0022-510x(99)00210-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  810 in total

1.  Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.

Authors:  Robert Küffner; Neta Zach; Raquel Norel; Johann Hawe; David Schoenfeld; Liuxia Wang; Guang Li; Lilly Fang; Lester Mackey; Orla Hardiman; Merit Cudkowicz; Alexander Sherman; Gokhan Ertaylan; Moritz Grosse-Wentrup; Torsten Hothorn; Jules van Ligtenberg; Jakob H Macke; Timm Meyer; Bernhard Schölkopf; Linh Tran; Rubio Vaughan; Gustavo Stolovitzky; Melanie L Leitner
Journal:  Nat Biotechnol       Date:  2014-11-02       Impact factor: 54.908

2.  Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm.

Authors:  Paul Wicks; Timothy E Vaughan; Michael P Massagli; James Heywood
Journal:  Nat Biotechnol       Date:  2011-04-24       Impact factor: 54.908

3.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

4.  Papez Circuit Gray Matter and Episodic Memory in Amyotrophic Lateral Sclerosis and Behavioural Variant Frontotemporal Dementia.

Authors:  Ana Paula Arantes Bueno; Leonardo Cruz de Souza; Walter Hugo Lopez Pinaya; Antônio Lúcio Teixeira; Laura Godoy Rousseff de Prado; Paulo Caramelli; Michael Hornberger; João Ricardo Sato
Journal:  Brain Imaging Behav       Date:  2021-04       Impact factor: 3.978

5.  Meditation training for people with amyotrophic lateral sclerosis and their caregivers.

Authors:  Francesco Pagnini; Chiara Di Credico; Ramona Gatto; Viviana Fabiani; Gabriella Rossi; Christian Lunetta; Anna Marconi; Federica Fossati; Gianluca Castelnuovo; Aurora Tagliaferri; Paolo Banfi; Massimo Corbo; Valeria Sansone; Enrico Molinari; Gherardo Amadei
Journal:  J Altern Complement Med       Date:  2013-12-11       Impact factor: 2.579

6.  Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient-caregiver dyads.

Authors:  Tom Burke; Orla Hardiman; Marta Pinto-Grau; Katie Lonergan; Mark Heverin; Katy Tobin; Anthony Staines; Miriam Galvin; Niall Pender
Journal:  J Neurol       Date:  2018-02-02       Impact factor: 4.849

7.  HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy.

Authors:  Lauren N Bowen; Richa Tyagi; Wenxue Li; Tariq Alfahad; Bryan Smith; Mary Wright; Elyse J Singer; Avindra Nath
Journal:  Neurology       Date:  2016-09-24       Impact factor: 9.910

8.  Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS.

Authors:  Charlotte J Stagg; Steven Knight; Kevin Talbot; Mark Jenkinson; Andrew A Maudsley; Martin R Turner
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

9.  Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Authors:  Pilar M Ferraro; Charles Jester; Christopher A Olm; Katerina Placek; Federica Agosta; Lauren Elman; Leo McCluskey; David J Irwin; John A Detre; Massimo Filippi; Murray Grossman; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

10.  Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications.

Authors:  Peter M Andersen; Magdalena Kuzma-Kozakiewicz; Jürgen Keller; Helena E A Aho-Oezhan; Katarzyna Ciecwierska; Natalia Szejko; Cynthia Vázquez; Sarah Böhm; Gisela Badura-Lotter; Thomas Meyer; Susanne Petri; Katharina Linse; Andreas Hermann; Olof Semb; Erica Stenberg; Simona Nackberg; Johannes Dorst; Ingo Uttner; Ann-Cristin Häggström; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2018-05-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.